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Abstract: Next-generation sequencing and metagenomics have revolutionized the discovery of novel
viruses. In recent years, three novel protoparvoviruses have been discovered in fecal samples of humans:
bufavirus (BuV) in 2012, tusavirus (TuV) in 2014, and cutavirus (CuV) in 2016. BuV has since been studied
the most, disclosing three genotypes that also represent serotypes. Besides one nasal sample, BuV DNA
has been found exclusively in diarrheal feces, but not in non-diarrheal feces, suggesting a causal
relationship. According to both geno- and seroprevalences, BuV appears to be the most common
of the three novel protoparvoviruses, whereas TuV DNA has been found in only a single fecal sample,
with antibody detection being equally rare. Moreover, the TuV sequence is closer to those of non-human
protoparvoviruses, and so the evidence of TuV being a human virus is thus far insufficient. Interestingly,
besides in feces, CuV has also been detected in skin biopsies of patients with cutaneous T-cell lymphoma
and a patient with melanoma, while all other skin samples have tested PCR negative. Even if preliminary
disease associations exist, the full etiological roles of these viruses in human disease are yet to be resolved.
Keywords: human protoparvovirus; bufavirus; tusavirus; cutavirus; discovery; epidemiology;
gastroenteritis; cutaneous T-cell lymphoma; emerging viruses
1. Introduction
Parvoviruses are small ssDNA viruses that infect a diverse group of animals; both vertebrates
(subfamily Parvovirinae) and invertebrates (subfamily Densovirinae). Their non-enveloped capsid
structure makes these viruses stable and very resistant to inactivation. Human parvoviruses are
generally not easy to grow in standard cell culture systems, limiting the discovery of novel human
parvoviruses in the past. However, in recent years great progress has been made in genetic sciences,
where virion enrichment, host DNA depletion, sequence-independent amplification, next generation
sequencing (NGS), and metagenomic analysis with diverse bioinformatic pipelines have revolutionized
the discovery of novel viruses, including human parvoviruses.
For 30 years, human parvovirus B19 of the Erythroparvovirus genus was the only known
indisputably human-pathogenic parvovirus, causing erythema infectiosum, arthropathies, anemias,
and fetal death, while the highly prevalent adeno-associated viruses (AAV) of the Dependoparvovirus genus
are apathogenic [1,2]. In 2005, two novel parvoviruses were discovered in humans: parvovirus 4 (PARV4)
of the Tetraparvovirus genus in blood, and human bocavirus 1 (HBoV1) of the Bocaparvovirus genus in
pediatric respiratory samples [3,4]. PARV4 is mainly detected in injecting drug users and hemophiliacs in
the western world, but has not been associated with any specific symptoms, whereas HBoV1 causes mild
to life-threatening respiratory tract infections in children [2]. Three more bocaviruses (HBoV2–4) have
been discovered in stool, without clear clinical associations [5–7]. During the past six years, three novel
parvoviruses have been described in humans, all belonging to the Protoparvovirus genus: bufavirus (BuV),
tusavirus (TuV), and cutavirus (CuV) [8–10]. Although BuV has been associated with gastrointestinal
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symptoms and CuV is under study for its possible role in skin cancers, the etiological roles of these viruses
in human disease are yet to be resolved. Here we review what is known about these new protoparvoviruses.
2. Bufavirus
2.1. Discovery and Taxonomy
Bufavirus was identified in 2012 in viral metagenomic analysis of fecal samples from diarrheic
children in Burkina Faso [8]. The obtained sequence reads from one sample showed significant
similarities to parvovirus sequences, and after filling the gaps between the NGS reads by PCR,
a nearly full-length sequence of 4921 bp (GenBank # JQ918261) was constructed showing <39%
and <31% identity of the NS1 (non-structural protein 1) and VP1 protein (viral capsid protein 1),
respectively, to previously known protoparvoviruses. A unique middle open reading frame (ORF)
of 130 amino acids was also identified that did not show similarity with any other parvovirus
sequences (Figure 1a). Further PCR analysis of 98 rotavirus antigen-negative diarrheal fecal samples
from Burkina Faso showed the presence of BuV DNA in 4/98 (4.1%) samples [8]. The complete
protein-coding regions were determined for all BuV DNA isolates. Within the VP2 (viral capsid protein
2) region, one of the four isolates shared less than 73% amino-acid identity with the other isolates,
whereas the non-structural NS1 regions were nearly identical. Subsequently, a second BuV genotype,
bufavirus 2 (BuV2), was identified (GenBank # JX027297). The authors further studied 100 fecal
samples from Chilean children with diarrhea and 63 samples from Tunisian children with non-polio
acute flaccid paralysis, but only one BuV sequence was found among the latter [8].
Two years later, a third BuV genotype, BuV3 (GenBank # AB847987-9), was discovered in
the diarrheal feces of 3/393 Bhutanese children [11]. All three current BuV genotypes contain
an ATP- or GTP-binding Walker loop, phospholipase A2 (PLA2), two conserved replication initiator
motifs, a glycine-rich sequence, and the same splice sites. Among the two major ORFs, the three
genotypes are more divergent within the capsid proteins, sharing only 71–78% amino-acid identity
within VP1 and 65–73% within VP2 [12]. In contrast, the NS1 regions of the three BuVs are nearly
identical (94–96% amino acid identity). According to the International Committee on Taxonomy of
Viruses (ICTV), parvoviruses in a single species encode NS1 proteins of >85% amino acid sequence
identity [13]. Therefore, all three BuV genotypes can be phylogenetically classified into one species:
Primate protoparvovirus 1, within the Protoparvovirus genus (Figure 1b).
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Figure 1. Schematic illustration of genomic structures and phylogenetic analyses of the sequences of 
BuVs, CuVs, TuV, and other members of Protoparvovirus. (a) Schematic illustration of BuV, TuV, CuV, 
and MVMp genomic structures. The hairpin regions are unknown for BuV, TuV, and CuV, and the 
hairpins of MVMp are represented as straight lines for this simplified scheme. Species, strain, 
GenBank no., and the length of genome are indicated; Phylogenetic analyses of (b) NS1 sequences; (c) 
VP2 sequences; (d) short middle ORF sequences (not available from TuV). The phylogenetic analysis 
was based on nucleic acid sequences. Sequences were aligned with ClustalX (Version 2.1) [14] using 
a protospacer adjacent motif (PAM) with a gap open penalty of 10 and gap extension penalty of 0.1. 
The neighbor-joining phylogenetic tree was generated with bootstrap values determined by 1000 
replicates in the Molecular Evolutionary Genetics Analysis (MEGA)(Version 7.0) [15]. The 
evolutionary distances were calculated by the p-distance method. Bootstrap values are shown if >80%. 
NS1, non-structural protein 1; mORF, short middle ORF; VP1, viral capsid protein 1; VP2, viral capsid 
protein 2; NS2, non-structural protein 2. 
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Figure 1. Schematic illustration of genomic structures and phylogenetic analyses of the sequences
of BuVs, CuVs, TuV, and other members of Protoparvovirus. (a) Schematic illustration of BuV, TuV,
CuV, and MVMp genomic structures. The hairpin regions are unknown for BuV, TuV, and CuV,
and the hairpins of MVMp are represented as straight lines for this simplified scheme. Species, strain,
GenBank no., and the length of genome are indicated; Phylogenetic analyses of (b) NS1 sequences;
(c) VP2 sequences; (d) short middle ORF sequences (not available from TuV). The phylogenetic
analysis was based on nucleic acid sequences. Sequences were aligned with ClustalX (Version 2.1) [14]
using a protospacer adjacent motif (PAM) with a gap open penalty of 10 and gap extension penalty
of 0.1. The neighbor-joining phylogenetic tree was generated with bootstrap values determined
by 1000 replicates in the Molecular Evolutionary Genetics Analysis (MEGA)(Version 7.0) [15].
The evolutionary distances were calculated by the p-distance method. Bootstrap values are shown
if >80%. NS1, non-structural protein 1; mORF, short middle ORF; VP1, viral capsid protein 1; VP2,
viral capsid protei 2; NS2, non-structural protein 2.
2.2. PCR-Based Epidemiology
BuV DNA has been mainly searched for in feces, the sample type that the virus was originally
identified in. BuV DNA has been detected in the diarrheal samples of children in Burkina Faso,
Tunisia, Bhutan, Thailand, Turkey, China, and Finland, and of adults in Finland, the Netherlands,
Thailand, and China (Table 1) [8,11,16–22]. In all studies, the BuV DNA prevalence in feces has been
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low, ranging from 0.3% to 4.1% (Table 1), and when reported, the viral titre was always low [16,22].
Recently, a partial sequence matching BuV3 was found by NGS in diarrheal feces from Peru in
South America, expanding the geographic locations where BuV DNA has been detected (Table 1) [23].
Prevalence variation may occur even within one country; in China, the BuV DNA prevalence was 1.7%
(9/520) among samples from the General Hospital of Beijing, whereas all samples (n = 1357) from
the Children’s hospital of Chongqing were BuV DNA-negative [20]. So far, all BuV-DNA findings
have been of genotypes 1 or 3, except the one original BuV2-DNA sequence from the single child in
Burkina Faso [8,11,16–21,23], showing that BuV1 and 3 are geographically widespread.
In six studies, temporal clustering of BuV DNA detection to cold weather was observed as
all or nearly all BuV DNA-positive samples were collected during September–April [11,18–22].
In four studies, negative controls were included; all fecal samples from non-diarrheic patients or healthy
individuals (total n = 1855) were BuV DNA-negative (Table 1) [18–20,22]. However, in only two studies
the non-diarrheal fecal samples were collected during the same time period as the BuV DNA-positive
diarrheal samples [19,22]. This is of importance as in most studies BuV DNA was not detected
throughout the year, and very often not at all during certain years.
Besides in feces, BuV DNA has been studied in nasal swabs of children and in cerebrospinal fluid
(CSF) samples of adults and children [22,24]. Nasal swabs (n = 955) were collected in Finland from
children with acute gastroenteritis (AGE, n = 172), acute respiratory tract infection (ARTI, n = 545),
or both (n = 238), and BuV DNA was detected at low copy number in the nasal swab of one child
with both AGE and ARTI (Table 1) [22]. However, the corresponding fecal sample of this child was
BuV DNA-negative. In a study of central nervous system infections in Turkey, the CSF samples were
collected from patients with a febrile disease and/or central nervous system infection with presumed
viral etiology [24]. However, no BuV DNA sequences were detected by nested PCR in the CSF from
these 93 Turkish children and 33 adults (Table 1).
Table 1. BuV DNA studies of subjects with or without diarrhea.
Study SampleType Country
Age (Range)
If Known Sampling Time n Positive (%) Symptoms Genotype
[8]
Feces Burkina Faso <5 yr November 2008–February 2010 98 4 (4.1%) GE
Three BuV1,
one BuV2
Feces Tunisia “children” NA 63 1 (1.6%) NPAFP unknown
Feces Chile “children” NA 100 0 (0.0%) GE -
[11] Feces Bhutan <5 yr February 2010–January 2012 393 3 (0.8%) GE All BuV3
[16] Feces Finland median 51.5 yr(0–99 yr)
October 2012–March 2013;
April–May 2013 629 7 (1.1%) GE
Six BuV1,
one unknown
[17] Feces The Netherlands median 47 yr(0–97 yr) 2005–2009 27 1 (3.7%) GE BuV3
[19]
Feces Thailand median NA(0–97 yr) January 2009–April 2014 1495 4 (0.3%) GE All BuV1
Feces Thailand median NA(0–39 yr) February 2010–July 2014 741 0 HFMD -
[18]
Feces Turkey mean 19.5 mo(1–60 mo) September 2004–June 2011 583 8 (1.4%) GE
Six BuV3,
two unknown
Feces Turkey
mean 17.3 mo
(NA),
age matched
February–September 2013 148 0 healthy -
[20]
Feces
China
(General hospital,
Beijing)
median 35 yr
(1 mo–85 yr) 2010–2014 520 9 (1.7%) GE
Four BuV1,
five BuV3
“children” NA 76 0 non-GE -
Feces
China
(Children’s hospital,
Chongqing)
median 10 mo
(1 day–14 yr) 2010–2013 1357 0 GE -
“children” NA 345 0 non-GE -
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Table 1. Cont.
Study SampleType Country
Age (Range)
If Known Sampling Time n Positive (%) Symptoms Genotype
[21] Feces Tunisia median 7.0 mo(0.5–60 mo) October 2010–March 2012 203 2 (1.0%) GE Both BuV1
[22]
Feces Finland
median 14 mo
(6 days–15.6 yr)
September 2009
–August 2011
172 2 (1.2%) GE Unknown 1
545 0 ARTI -
238 1 (0.4%) GE & ARTI Unknown 1
nasal swab Finland
median 14 mo
(6 days–15.6 yr)
September 2009
–August 2011
172 0 GE -
545 0 ARTI -
238 1 (0.4%) GE & ARTI Unknown 1
[24] CSF Turkey median 32 yr(0–96 yr) October 2011–April 2015 126 0
febrile illness
and/or CNS
infection
-
[23] Feces Peru Unknown NA 300 Unknown 2 GE BuV3
1 Short sequence only from conserved NS1 region, cannot separate genotypes; 2 by NGS, only the presence of BuV3
sequence was reported, prevalence cannot be calculated; ARTI, acute respiratory tract infection; CNS, central nervous
system; CSF, cerebrospinal fluid; GE, gastroenteritis; HFMD, hand, foot, and mouth disease; mo, month(s); NA,
not available; non-GE, patients who had sought medical care from the same hospitals for reasons other than GE; NPAFP,
non-polio acute flaccid paralysis; yr, year(s); n of the non-diarrheic control patients are bolded.
2.3. Antibody-Based Epidemiology
A BuV enzyme immunoassay (EIA) has been developed to elucidate the prevalence of BuV1–3
IgG antibodies in various populations [22]. Humans have been shown to induce BuV IgG towards each
of the three genotypes (Table 2). The BuV IgG prevalence was low in both Finnish-born adults (3.1%)
and children (3.1%). Interestingly, among Asian-born university or hospital staff members working in
Finland, BuV IgG was present in 5/12 of the tested subjects, suggesting that BuV is more prevalent
in Asia [22]. The study moreover highlighted that the three BuV genotypes also represent serotypes,
as no antibody cross-reactivity in EIA was observed. Further studies with larger cohorts from different
parts of the world are ongoing to reveal the global BuV IgG prevalences in healthy populations and in
different patient cohorts. In addition, no patients with serologically confirmed acute BuV infections
have yet been reported. Such cases would be essential in order to broaden the knowledge of possible
symptoms and diseases that BuV might cause.
Table 2. BuV IgG-positive adults and children. The origins of the subjects are shown in the header.
Genotype
Adults Children
Asia, n = 12
Finland, n = 163 Finland, n = 228
Middle East India China
BuV1 1 1 3 1 2 2
BuV2 1 1 1 4 4 2
BuV3 1 1 2
Any BuV 1 1 3 1 5 7 2
1 One individual was positive for all three BuVs; 2 one individual was positive for both BuV1 and BuV2; Any BuV,
sums of the BuV IgG-positive individuals.
2.4. Bufavirus-Like Animal Viruses
Since the discovery of human BuV, several animal species have been shown to have their own
BuV-like viruses. The viruses phylogenetically closest to human BuVs have been detected in captive
rhesus monkeys in the USA with a nucleotide identity of 77% in the VP1 gene, and in wild baboons in
Zambia (Figure 1) [25,26]. In both primate species, BuV-like viruses were detected either in the blood
or in the spleen of the animal, indicating that these BuV-like viruses can cause systemic infections.
Besides in primates, BuV-like viruses have so far also been identified in shrews, bats, rats, swine,
and fur seals [12,26–30].
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3. Tusavirus
Tusavirus, the name corresponding to Tunisian stool-associated parvovirus, was identified in 2014
using NGS and metagenomics in the fecal sample of an 18-month-old child with unexplained diarrhea
in Tunisia [10]. Only one pool showed a single read of a parvovirus-like sequence, which was most
similar to the NS1 sequence of a rat protoparvovirus. A near-complete genome sequence of 4424 bp was
obtained (GenBank # KJ495710), including the two major ORFs, NS1 and VP1, typical of parvoviruses.
Two conserved replication initiator sites and the Walker loop were also identified within NS1, as well as the
PLA2 motif and an unusual serine-rich sequence near the VP1 N-terminus. TuV was shown to be
quite distant from other protoparvoviruses: NS1 and VP1 showing the closest identities of 44% and
39%, respectively, to the Kilham rat parvovirus (Figure 1). TuV was thus proposed to be the prototype
member for a new species, Primate protoparvovirus 2, in the Protoparvovirus genus [10]. However, the final
classification is still pending due to the scarcity of this virus. No other TuV sequences were found in these
Tunisian fecal samples by a nested PCR targeting the NS1 gene, and thus the TuV DNA was present in
only 1/180 (0.56%) diarrheal fecal samples. However, no other human-pathogenic viruses were detected in
this sample.
No other studies of TuV DNA prevalence in any sample type have been reported, and only one
other metagenomics study has disclosed sequences showing resemblance to TuV: a study of fur seals
in Brazil described partial sequences ranging from 344 to 1519 nt in length, of both NS1 and VP regions
with 39–82% similarity to TuV at the amino acid level [30]. Besides DNA, one serological study of
TuV IgG in humans has been published, in which one child in Finland was shown by EIA to be barely
positive for TuV IgG (1/228, 0.44%) [22].
4. Cutavirus
In 2016, yet another protoparvovirus, cutavirus, was detected by viral metagenomics in 2/245
diarrheal fecal samples from Brazilian children [9]. The near full-length 4456 bp sequence (GenBank
# KT868811) of the CuV genome showed the typical major ORFs for NS1 and VP1 with 76% and
82% amino acid identity, respectively, to those of BuV2, the phylogenetically closest parvovirus,
suggesting that CuV may be a distinct protoparvovirus species (Figure 1). The CuV NS1 gene
was, however, shorter than that of BuV; the alignment revealing an 11 amino-acid deletion near the
C-terminus. The CuV genome was shown to contain the typical NS1 helicase motif with NTP-binding
domains, as well as the VP1 PLA2 motif and glycine-rich regions. In addition, the sequence included
a BuV-like middle ORF of unknown function, 20 amino acids shorter than that of BuV, with a 45%
identity (Figure 1).
By CuV VP-specific nested PCR, three more CuV sequences were detected, 2 more in Brazilian fecal
samples and one in one hundred fecal samples from Botswana. In all, the CuV DNA fecal prevalence
was 4/245, 1.6%, in Brazilian and 1/100, 1.0%, in Botswanan diarrheic children [9]. These CuV genomes
were only partly sequenced. To search for other pathogens in the five CuV DNA-positive samples,
NGS was performed on the individual samples. In one of the Brazilian samples, no other human
viruses were detected [9]. In the other three Brazilian samples, one contained rotavirus A and AAV,
one astrovirus and adenovirus, and one rotavirus A and anellovirus. The Botswanan sample harbored
both picobirna- and anellovirus.
Interestingly, by further in silico screening of existing NGS libraries, CuV DNA was retrospectively
detected in two skin biopsies of French cutaneous T-cell lymphoma (CTCL) patients, thereby resulting
in the virus name [9]. By CuV-nested PCR, 15 additional CTCL skin samples were screened, of which
two more (2/15, 13.3%) were found to be CuV DNA-positive. Skin samples of other cancers (n = 10)
and non-malignant skin biopsies (n = 19) were all CuV PCR-negative (Table 3). Later on, CuV DNA
was detected with NGS in the malignant skin lesions of one melanoma patient in Denmark [31],
while 9 additional melanoma samples were CuV DNA-negative when using both NGS and PCR.
The CuV nt sequence from Denmark was 96.5–93.7% identical to the previously published three
sequences covering the entire NS1 and VP coding regions (Table 4, data calculated for this review,
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and Figure 1). When comparing all known CuV nt sequences (of 3980 nt in length), the BR-283
sequence from Brazilian feces was closer to the Danish and French sequences from skin than to the
other Brazilian sequences (Table 4). These data indicate that the sequences of CuV strains found in
skin and feces are similar.
Table 3. CuV DNA prevalences in fecal and skin samples.
Study Sample Type Country n Positive (%) Symptoms/Diagnosis
[9] Feces Brazil 245 4 (1.6%) Diarrhea
[9] Feces Botswana 100 1 (1.0%) Diarrhea
[9] Skin France 1 NA 2 CTCL, Mycosis fungoides
[9] Skin France 15 2 (13.3%) CTCL, Mycosis fungoides
[9] Skin France 10 0 (0%) Skin carcinoma
[9] Skin France 1 NA 0 Parapsoriasis
[9] Skin 2 France; 6 NA 8 0 (0%) Parapsoriasis
[9] Skin NA 8 0 (0%) Eczema or eczematoid dermatitis
[9] Skin NA 3 0 (0%) Healthy
[31] Skin Denmark 10 1 (10%) Melanoma
1 2 CuV DNA-positive skin samples from CTCL patients were detected with NGS and PCR. However, it is not
known how many CTCL skin samples were tested by NGS, whereby these 2 cases are not included in the overall
prevalence. The same holds for the 2 CuV DNA-negative parapsoriasis skin samples tested in NGS pools. NA,
not available; CTCL, cutaneous T-cell lymphoma.
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Table 4. Nucleotide identities between the currently available CuV sequences. A sequence of approximately 3980 nts, covering the partial NS1 and complete VP regions (nts
474–4456 of BR-337 [KT868811]) was used for calculations. Strain, sample type, and GenBank no. indicated.
% Nucleotide Identity
BR-337, Feces
[KT868811]
BR-283, Feces
[KT868810]
BR-372, Feces
[KT868809]
BR-450, Feces
[KT868812]
BO-46, Feces
[KT868813]
FR-D, Skin
[KT868813]
FR-F, Skin
[KT868813]
CGG5-268, Skin
[KX685945]
BR-337, feces [KT868811] 100.0
BR-283, feces [KT868810] 94.4 100.0
BR-372, feces [KT868809] 99.5 94.6 100.0
BR-450, feces [KT868812] 96.9 94.4 97.1 100.0
BO-46, feces [KT868813] 93.9 96.0 94.1 93.9 100.0
FR-D, skin [KT868813] 93.8 96.2 93.8 93.9 95.0 100.0
FR-F, skin [KT868813] 94.4 96.6 94.5 94.5 95.5 95.9 100.0
CGG5-268, skin [KX685945] 94.1 97.1 94.2 94.2 96.0 96.1 96.7 100.0
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5. Discussion
Three protoparvoviruses, BuV, TuV and CuV, are the newest parvoviruses identified among
humans [8–10]. All three were originally discovered in diarrheal feces of children by using virion
enrichment and nuclease treatment prior to NGS, suggesting that the discovered viral DNA in the
samples might have been protected by a capsid structure. No cell culture experiments have been done.
The subsequent studies have instead focused on finding the DNAs of these viruses, or antibodies
towards them, in human samples. As parvoviruses generally infect host-specifically and human
parvoviruses grow poorly in cell cultures, DNA and antibody detection are the most feasible ways to
establish these viruses as human viruses. Studies and findings on TuV DNA or antibodies are, however,
scarce; only one DNA isolate exists and only one child has been barely TuV IgG-positive [10,22].
Whether TuV truly is a human parvovirus and not of, e.g., dietary origin, requires further investigation.
Of these three protoparvoviruses, BuV was discovered first and has been studied the most.
The fact that BuV DNA is found near-exclusively in the feces of patients with diarrhea, often without
other pathogen coinfections, whereas non-diarrheal fecal samples all have been BuV DNA-negative,
suggests that BuV might be causative for gastroenteritis. However, the low viral loads and infrequent
detection of BuV DNA point to a less prominent role in the overall burden of gastroenteritis.
Whether BuV is involved in other clinical manifestations is not yet known, as acute primary BuV
infections have not yet been serologically identified. The presence of IgG in humans, however,
indicates that BuV is a true, capsid-covered infectious virus. The remarkable difference in BuV
seroprevalence between Finland and Asia is interesting and under ongoing investigation. The reasons
for such diversity might be cultural, genetic, or demo-geographic.
The newest member of the human protoparvoviruses is CuV, the DNA of which has been detected
both in the diarrheal feces of children and in 4/17 skin samples of patients with CTCL (mycosis
fungoides), whereas all 31 non-CTCL skin biopsies were PCR negative [9]. In addition, one Danish
melanoma skin biopsy was found to be CuV DNA-positive. That the virus has been detected both in
feces and skin suggests that CuV is a human virus and may cause systemic infection. Further PCR and
sero-epidemiological studies are ongoing to assess the cancer association and the global distribution of
this novel human virus.
In conclusion, according to DNA and antibody data, BuV and CuV are indeed human viruses,
whereas for TuV the evidence is inconclusive. Further DNA studies of diverse sample materials
combined with serological analyses are needed to establish the pathogenicity, or the absence of it,
regarding, in particular, gastrointestinal and neoplastic illnesses.
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